# SymBio Pharmaceuticals Limited (SYMQY)

> Healthcare · JP · Reports in JPY

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/SYMQY/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | ¥ 477.37M | ¥ -3.68B | ¥ 0 | ¥ 827.00M | ¥ -579.00M |
| 2025 | ¥ 1.31B | ¥ -4.80B | ¥ 0 | ¥ 1.98B | ¥ 1.27B |
| 2024 | ¥ 2.45B | ¥ -3.83B | ¥ 0 | ¥ 0 | ¥ 4.20B |
| 2023 | ¥ 5.59B | ¥ -1.96B | ¥ 192.01M | ¥ 0 | ¥ 7.21B |
| 2022 | ¥ 10.01B | ¥ 1.18B | ¥ 99.42M | ¥ 0 | ¥ 8.51B |
| 2021 | ¥ 8.25B | ¥ 2.03B | ¥ 0 | ¥ 0 | ¥ 6.75B |
| 2020 | ¥ 2.97B | ¥ -4.06B | ¥ 0 | ¥ 0 | ¥ 4.66B |
| 2019 | ¥ 2.78B | ¥ -4.29B | ¥ 0 | ¥ 0 | ¥ 4.40B |
| 2018 | ¥ 3.79B | ¥ -2.72B | ¥ 0 | ¥ 0 | ¥ 4.90B |
| 2017 | ¥ 3.42B | ¥ -3.95B | ¥ 0 | ¥ 0 | ¥ 3.24B |
| 2016 | ¥ 2.37B | ¥ -2.32B | ¥ 0 | ¥ 450.00M | ¥ 5.48B |
| 2015 | ¥ 1.94B | ¥ -2.65B | ¥ 0 | ¥ 642.0K | ¥ 4.43B |
| 2014 | ¥ 1.97B | ¥ -1.12B | ¥ 0 | ¥ 1.33M | ¥ 6.96B |
| 2013 | ¥ 1.58B | ¥ -1.66B | ¥ 0 | ¥ 2.02M | ¥ 7.43B |
| 2012 | ¥ 2.05B | ¥ -1.82B | N/A | ¥ 2.69M | ¥ 4.90B |
| 2011 | ¥ 1.97B | ¥ -2.20B | ¥ -2.17B | ¥ 3.41M | ¥ 6.61B |
| 2010 | N/A | N/A | N/A | ¥ 0 | ¥ 4.08B |
| 2009 | N/A | N/A | N/A | ¥ 0 | ¥ 4.05B |
| 2008 | N/A | N/A | N/A | ¥ 0 | ¥ 1.31B |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | -1.43 |
| Liabilities / Eq | -4.27 |
| Current Ratio | 0.75 |

## Debt coverage

| Indicator | Value |
| --- | --- |
| Gross Debt / FCF | 28.38 |

## Other views

- [Metrics](https://sponda.capital/en/SYMQY.md)
- [Charts](https://sponda.capital/en/SYMQY/charts.md)
- [Compare](https://sponda.capital/en/SYMQY/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-29.